A pivotal phase III study of PD-protec® in patients suffering from end-stage renal disease
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Alanylglutamine (Primary)
- Indications Peritonitis
- Focus Registrational; Therapeutic Use
- Sponsors Zytoprotec
- 19 Dec 2017 New trial record